In 2012, it was discovered as an ingredient in synthetic cannabinoid blends in Japan, together with a related compound AB-PINACA, which had not beforehand been reported. Twenty-three ADB-FUBINACA major metabolites have been identified in several incubations with cryopreserved human hepatocytes. Major metabolic pathways have been alkyl and indazole hydroxylation, terminal
